Browsing Tag
Canadian biotech
1 post
Is a C$16m LIFE offering from ZYUS Life Sciences the catalyst investors are watching in cannabinoid pharma?
ZYUS Life Sciences launches a C$15–16 million LIFE offering to accelerate clinical execution and regulatory readiness. Find out what it means for investors.